Toronto Dominion Bank Reduces Stock Holdings in Danaher Co. (NYSE:DHR)

Toronto Dominion Bank reduced its position in shares of Danaher Co. (NYSE:DHR - Free Report) by 3.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 363,402 shares of the conglomerate's stock after selling 12,950 shares during the quarter. Toronto Dominion Bank owned about 0.05% of Danaher worth $83,416,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also bought and sold shares of DHR. Heck Capital Advisors LLC purchased a new position in shares of Danaher in the 4th quarter valued at $27,000. Decker Retirement Planning Inc. purchased a new position in Danaher in the fourth quarter valued at about $31,000. Golden State Wealth Management LLC purchased a new position in Danaher in the fourth quarter valued at about $31,000. Strategic Financial Concepts LLC purchased a new stake in shares of Danaher during the fourth quarter valued at about $31,000. Finally, Pineridge Advisors LLC boosted its holdings in shares of Danaher by 63.3% in the 4th quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate's stock valued at $34,000 after buying an additional 57 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Danaher news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. This represents a 51.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the business's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now owns 3,105,808 shares in the company, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DHR. Royal Bank of Canada reaffirmed an "outperform" rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, April 23rd. Barclays increased their price objective on shares of Danaher from $205.00 to $215.00 and gave the company an "overweight" rating in a research report on Tuesday, April 22nd. StockNews.com raised shares of Danaher from a "hold" rating to a "buy" rating in a research report on Monday, May 12th. Wells Fargo & Company cut their price target on shares of Danaher from $280.00 to $240.00 and set an "equal weight" rating on the stock in a research note on Thursday, January 30th. Finally, Citigroup reiterated a "buy" rating on shares of Danaher in a research note on Monday, April 7th. Four research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $263.24.

Danaher Price Performance

Shares of Danaher stock traded down $11.28 on Wednesday, reaching $186.50. The company's stock had a trading volume of 5,613,061 shares, compared to its average volume of 3,467,857. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70. The company has a market capitalization of $133.47 billion, a P/E ratio of 35.32, a PEG ratio of 2.66 and a beta of 0.80. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. The stock has a 50-day moving average price of $196.56 and a 200-day moving average price of $216.78.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. Analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.69%. Danaher's payout ratio is 24.85%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.